FDA Adverse Event Injury Summary report: N

GORE EXCLUDER AAA ENDOPROSTHESIS

MDR report key: 12257958 · Received August 2, 2021

Report

Report Number
3007284313-2021-01529
Event Type
Injury
Date Received
August 2, 2021
Date of Event
July 12, 2021
Report Date
August 2, 2021
Manufacturer
W. L. GORE & ASSOCIATES, INC.
Product Code
MIH
PMA / PMN Number
P020004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SW
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

NO PATIENT SPECIFIC DETAILS HAVE BEEN PROVIDED. THEREFORE, THE PATIENT INITIALS REFLECT THE W. L. GORE INTERNAL CASE NUMBER. THE DATE OF INCIDENT IS UNKNOWN. THEREFORE, THE ONLINE PUBLICATION DATE OF THE LITERATURE ARTICLE IS USED AS DATE OF EVENT. REVIEW OF THE MANUFACTURING AND STERILIZATION RECORDS COULD NOT BE PERFORMED AS A VALID LOT NUMBER WAS NOT PROVIDED.

Description of Event or Problem · 1

THE LITERATURE ARTICLE: "LIMB GRAFT OCCLUSION FOLLOWING ENDOVASCULAR ANEURYSM REPAIR FOR INFRARENAL ABDOMINAL AORTIC ANEURYSM WITH THE ZENITH ALPHA, EXCLUDER, AND ENDURANT DEVICES: A MULTICENTRE COHORT STUDY" PUBLISHED BY BOGDANOVIC M, STACKELBERG O, LINDSTRÖM D, ET AL. WAS REVIEWED. THE ARTICLE WAS MADE AVAILABLE ONLINE JUL 12, 2021, IN EUROPEAN JOURNAL OF VASCULAR & ENDOVASCULAR SURGERY. THE PAPER DISCUSSES HOW DIFFERENT ENDOGRAFT TYPES AFFECTS THE RISK OF LIMB GRAFT OCCLUSION (LGO). BETWEEN JANUARY 2012 AND DECEMBER 2018, 924 PATIENTS WERE INCLUDED IN THE STUDY WERE 152 WERE TREATED WITH GORE® EXCLUDER® AAA ENDOPROSTHESIS. IN THIS GROUP, THE MAJORITY WERE MALE AND THE MEAN AGE WAS 75.4±8 YEARS. ONE PATIENT WITH THE GORE® EXCLUDER® AAA ENDOPROSTHESIS EXPERIENCED OCCLUSION AFTER ONE MONTH FOLLOWUP, CORRESPONDING TO A OVERALL INCIDENCE RATE OF LGO TO 0.7%. NO PATIENT SPECIFIC INFORMATION REGARDING THE REPORTED EVENTS AND INTERVENTIONS WAS PROVIDED IN THE ARTICLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1157040 GORE EXCLUDER AAA ENDOPROSTHESIS SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W. L. GORE & ASSOCIATES, INC.

Patients

Seq Age Sex Outcome Treatment
1 75 YR Required Intervention